Even by dramatically lowering the prices of some of its medications, the drug giant is still outpacing its rivals and nearing ...

Medicare beneficiaries will soon be able to get obesity and Type 2 diabetes drugs for a $50 copay. But there are some ...

The Trump administration portrays its deals with drug manufacturers as major victories against rising drug prices — but they ...

The deal, with Eli Lilly and Novo Nordisk, is expected to lower the price of obesity drugs to between $149 and $350 per month ...

P res. Donald Trump says Americans could soon pay far less for GLP-1 medications used for diabetes, obesity, and heart ...

Competition is working, even as the FTC meddles in a takeover fight in a way that helped Pfizer.

The Trump administration is expected to announce deals with Eli Lilly and Novo Nordisk to cut prices of some weight loss ...

The voluntary model for states, called GENErating cost Reductions fOr U.S. Medicaid (GENEROUS) allows state Medicaid programs ...

The Trump administration announced deals on Thursday with pharmaceutical giants Novo Nordisk and Eli Lilly that would lower ...

The White House announced reduced pricing for the popular weight-loss drugs made by Eli Lilly and Novo Nordisk.

Plaintiffs in a sweeping antitrust case over generic drug pricing have asked a federal judge to intervene against a group of ...